AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 99 filers reported holding AVROBIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $7,187 | -98.4% | 10,082 | -98.6% | 0.00% | – |
Q3 2022 | $454,000 | +233.8% | 706,838 | +376.2% | 0.00% | – |
Q2 2022 | $136,000 | -62.1% | 148,446 | -45.4% | 0.00% | – |
Q1 2022 | $359,000 | -93.3% | 271,749 | -80.3% | 0.00% | -100.0% |
Q4 2021 | $5,319,000 | +120.6% | 1,381,758 | +219.7% | 0.00% | 0.0% |
Q3 2021 | $2,411,000 | -37.2% | 432,138 | +0.0% | 0.00% | 0.0% |
Q2 2021 | $3,841,000 | -10.1% | 432,105 | +28.3% | 0.00% | 0.0% |
Q1 2021 | $4,273,000 | -36.8% | 336,739 | -30.5% | 0.00% | -50.0% |
Q4 2020 | $6,758,000 | +14.4% | 484,797 | +6.9% | 0.00% | 0.0% |
Q3 2020 | $5,906,000 | -3.1% | 453,574 | +29.9% | 0.00% | 0.0% |
Q2 2020 | $6,095,000 | +329.8% | 349,269 | +283.4% | 0.00% | – |
Q1 2020 | $1,418,000 | -16.8% | 91,108 | +7.6% | 0.00% | – |
Q4 2019 | $1,704,000 | +32.6% | 84,652 | -7.0% | 0.00% | – |
Q3 2019 | $1,285,000 | +3.8% | 91,060 | +19.6% | 0.00% | – |
Q2 2019 | $1,238,000 | -28.1% | 76,153 | -2.5% | 0.00% | -100.0% |
Q1 2019 | $1,723,000 | +378.6% | 78,141 | +261.6% | 0.00% | – |
Q4 2018 | $360,000 | -76.0% | 21,609 | -58.8% | 0.00% | – |
Q2 2018 | $1,499,000 | – | 52,480 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,191,676 | $16,612,000 | 8.00% |
Aisling Capital Management LP | 1,009,779 | $14,076,000 | 2.42% |
Burrage Capital Management LLC | 145,715 | $2,031,000 | 1.55% |
Camber Capital Management LP | 3,133,333 | $43,679,000 | 1.53% |
New Leaf Venture Partners, L.L.C. | 315,550 | $4,399,000 | 1.02% |
SPHERA FUNDS MANAGEMENT LTD. | 655,874 | $9,143,000 | 0.81% |
EMERALD ADVISERS, LLC | 1,009,212 | $14,068,000 | 0.47% |
Penn Mutual Asset Management, LLC | 37,306 | $520,000 | 0.46% |
EMERALD MUTUAL FUND ADVISERS TRUST | 932,627 | $13,001,000 | 0.45% |
MPM BioImpact LLC | 364,285 | $5,078,000 | 0.44% |